Literature DB >> 9374513

Kinetic pathway for the slow to fast transition of thrombin. Evidence of linked ligand binding at structurally distinct domains.

M T Lai1, E Di Cera, J A Shafer.   

Abstract

The kinetic pathway for the Na+-induced slow --> fast transition of thrombin was characterized. The slow form was shown to consist of two conformers in a 3:1 ratio (ES2:ES1) at 5 degrees C, pH 7.4, Gamma/2 0.3. ES2 binds Na+ 3 orders of magnitude faster than does ES1. The small molecule active site-directed inhibitor L-371,912, and the exosite I binding ligand hirugen, like Na+, bind selectively to ES2 and induce the slow --> fast conversion of thrombin. The slow --> fast transition is limited by the rate of conversion of ES1 to ES2 (k approximately 28 s-1 at 5 degrees C). Replacement of Arg-221a or Lys-224 at the Na+ binding site with Ala appears to selectively alter the slow form and reduce the apparent affinity of the mutants for Na+ and L-371,912. This replacement, however, has little effect on the affinity for the inhibitor in the presence of saturating concentrations of Na+. The kinetically linked ligand binding at the Na+ binding site, exosite I, and the active site of thrombin characterized in the present study indicates the basis for the plasticity of this important enzyme, and suggests the possibility that the substrate specificity and, therefore, the procoagulant and anticoagulant activities of thrombin may be subject to allosteric regulation by as yet unidentified physiologically important effectors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9374513     DOI: 10.1074/jbc.272.48.30275

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Conformational selection or induced fit? A critical appraisal of the kinetic mechanism.

Authors:  Austin D Vogt; Enrico Di Cera
Journal:  Biochemistry       Date:  2012-07-16       Impact factor: 3.162

2.  Kinetic dissection of the pre-existing conformational equilibrium in the trypsin fold.

Authors:  Austin D Vogt; Pradipta Chakraborty; Enrico Di Cera
Journal:  J Biol Chem       Date:  2015-07-27       Impact factor: 5.157

3.  Effect of Na+ binding on the conformation, stability and molecular recognition properties of thrombin.

Authors:  Vincenzo De Filippis; Elisa De Dea; Filippo Lucatello; Roberta Frasson
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

4.  Structural identification of the pathway of long-range communication in an allosteric enzyme.

Authors:  Prafull S Gandhi; Zhiwei Chen; F Scott Mathews; Enrico Di Cera
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

5.  Mutant N143P reveals how Na+ activates thrombin.

Authors:  Weiling Niu; Zhiwei Chen; Leslie A Bush-Pelc; Alaji Bah; Prafull S Gandhi; Enrico Di Cera
Journal:  J Biol Chem       Date:  2009-10-21       Impact factor: 5.157

6.  Visualizing correlated motion with HDBSCAN clustering.

Authors:  Ryan L Melvin; Jiajie Xiao; Ryan C Godwin; Kenneth S Berenhaut; Freddie R Salsbury
Journal:  Protein Sci       Date:  2017-09-06       Impact factor: 6.725

Review 7.  Essential role of conformational selection in ligand binding.

Authors:  Austin D Vogt; Nicola Pozzi; Zhiwei Chen; Enrico Di Cera
Journal:  Biophys Chem       Date:  2013-09-25       Impact factor: 2.352

8.  Rigidification of the autolysis loop enhances Na(+) binding to thrombin.

Authors:  Nicola Pozzi; Raymond Chen; Zhiwei Chen; Alaji Bah; Enrico Di Cera
Journal:  Biophys Chem       Date:  2011-04-12       Impact factor: 2.352

9.  Expression of allosteric linkage between the sodium ion binding site and exosite I of thrombin during prothrombin activation.

Authors:  Heather K Kroh; Guido Tans; Gerry A F Nicolaes; Jan Rosing; Paul E Bock
Journal:  J Biol Chem       Date:  2007-04-12       Impact factor: 5.157

10.  Na+ binding to meizothrombin desF1.

Authors:  M E Papaconstantinou; P S Gandhi; Z Chen; A Bah; E Di Cera
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.